Kalbe Farma Tbk PT (JK:KLBF) — Stock Price
Kalbe Farma Tbk PT (JK:KLBF) is currently trading at Rp735.00 IDR, up 0.00% today. Over the past 52 weeks, shares have ranged between Rp665.00 and Rp1330.00. This page tracks Kalbe Farma Tbk PT's live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see KLBF stock market capitalisation.
Kalbe Farma Tbk PT (KLBF) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Kalbe Farma Tbk PT's daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.
Kalbe Farma Tbk PT Income Statement — Revenue, Profit & Earnings by Year
Kalbe Farma Tbk PT's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rp35.32 Trillion | Rp32.63 Trillion | Rp30.45 Trillion | Rp28.93 Trillion | Rp26.26 Trillion |
| Cost of Revenue | Rp21.27 Trillion | Rp19.67 Trillion | Rp18.90 Trillion | Rp17.23 Trillion | Rp14.98 Trillion |
| Gross Profit | Rp14.06 Trillion | Rp12.96 Trillion | Rp11.55 Trillion | Rp11.70 Trillion | Rp11.28 Trillion |
| Research & Development | Rp499.71 Billion | Rp471.60 Billion | Rp627.26 Billion | Rp288.34 Billion | Rp532.79 Billion |
| SG&A | Rp593.02 Billion | Rp556.93 Billion | Rp559.77 Billion | Rp501.54 Billion | Rp516.14 Billion |
| Total Operating Expenses | Rp9.51 Trillion | Rp8.89 Trillion | Rp7.92 Trillion | Rp7.47 Trillion | Rp7.28 Trillion |
| Operating Income | Rp4.55 Trillion | Rp4.07 Trillion | Rp3.63 Trillion | Rp4.49 Trillion | Rp4.16 Trillion |
| EBITDA | Rp5.18 Trillion | Rp4.61 Trillion | Rp4.43 Trillion | Rp5.25 Trillion | Rp4.87 Trillion |
| EBIT | Rp4.81 Trillion | Rp4.28 Trillion | Rp3.70 Trillion | Rp4.51 Trillion | Rp4.20 Trillion |
| Interest Expense | Rp35.25 Billion | Rp69.23 Billion | Rp95.10 Billion | Rp55.06 Billion | Rp57.38 Billion |
| Income Before Tax | Rp4.78 Trillion | Rp4.22 Trillion | Rp3.61 Trillion | Rp4.46 Trillion | Rp4.14 Trillion |
| Income Tax Expense | Rp1.03 Trillion | Rp972.30 Billion | Rp827.83 Billion | Rp1.01 Trillion | Rp911.26 Billion |
| Net Income | Rp3.66 Trillion | Rp3.24 Trillion | Rp2.77 Trillion | Rp3.38 Trillion | Rp3.18 Trillion |
Kalbe Farma Tbk PT Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Kalbe Farma Tbk PT's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rp30.70 Trillion | Rp29.43 Trillion | Rp27.06 Trillion | Rp27.24 Trillion | Rp25.67 Trillion |
| Total Current Assets | Rp18.51 Trillion | Rp17.19 Trillion | Rp15.92 Trillion | Rp16.71 Trillion | Rp15.71 Trillion |
| Cash & Equivalents | Rp1.80 Trillion | Rp3.09 Trillion | Rp1.91 Trillion | Rp2.32 Trillion | Rp3.32 Trillion |
| Short-term Investments | Rp154.14 Billion | Rp143.14 Billion | Rp165.50 Billion | Rp145.31 Billion | Rp258.92 Billion |
| Net Receivables | Rp5.90 Trillion | Rp5.01 Trillion | Rp4.82 Trillion | Rp4.79 Trillion | Rp4.10 Trillion |
| Inventory | Rp6.99 Trillion | Rp6.50 Trillion | Rp6.94 Trillion | Rp7.03 Trillion | Rp5.09 Trillion |
| Property, Plant & Equipment | Rp8.74 Trillion | Rp8.78 Trillion | Rp8.51 Trillion | Rp8.33 Trillion | Rp8.10 Trillion |
| Goodwill | Rp626.80 Billion | Rp615.45 Billion | Rp479.35 Billion | Rp479.35 Billion | Rp209.68 Billion |
| Total Liabilities | Rp5.97 Trillion | Rp4.84 Trillion | Rp3.94 Trillion | Rp5.14 Trillion | Rp4.40 Trillion |
| Total Current Liabilities | Rp5.34 Trillion | Rp4.19 Trillion | Rp3.24 Trillion | Rp4.43 Trillion | Rp3.53 Trillion |
| Long-term Debt | Rp143.02 Billion | Rp194.98 Billion | Rp298.34 Billion | Rp287.03 Billion | Rp490.28 Billion |
| Net Debt | Rp-4.03 Trillion | Rp-4.16 Trillion | Rp-2.61 Trillion | Rp-2.78 Trillion | Rp-5.59 Trillion |
| Total Stockholder Equity | Rp23.31 Trillion | Rp24.59 Trillion | Rp23.12 Trillion | Rp22.10 Trillion | Rp21.27 Trillion |
| Retained Earnings | Rp24.94 Trillion | Rp22.94 Trillion | Rp21.16 Trillion | Rp20.19 Trillion | Rp18.47 Trillion |
Kalbe Farma Tbk PT Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Kalbe Farma Tbk PT generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rp3.27 Trillion | Rp4.79 Trillion | Rp2.91 Trillion | Rp3.77 Trillion | Rp2.83 Trillion |
| Capital Expenditures | Rp809.87 Billion | Rp1.25 Trillion | Rp1.18 Trillion | Rp870.10 Billion | Rp1.00 Trillion |
| Free Cash Flow | Rp2.46 Trillion | Rp3.53 Trillion | Rp1.73 Trillion | Rp2.90 Trillion | Rp1.83 Trillion |
| Investing Cash Flow | Rp-799.89 Billion | Rp-1.25 Trillion | Rp-1.14 Trillion | Rp-1.37 Trillion | Rp-1.06 Trillion |
| Financing Cash Flow | Rp-2.87 Trillion | Rp-2.09 Trillion | Rp-2.39 Trillion | Rp-2.41 Trillion | Rp-745.18 Billion |
| Dividends Paid | Rp1.64 Trillion | Rp1.43 Trillion | Rp1.76 Trillion | Rp1.63 Trillion | Rp1.31 Trillion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rp804.52 Billion | Rp783.14 Billion | Rp731.48 Billion | Rp387.24 Billion | Rp673.81 Billion |
| Change in Cash | Rp-391.85 Billion | Rp1.49 Trillion | Rp-717.35 Billion | Rp-2.27 Trillion | Rp1.01 Trillion |
Kalbe Farma Tbk PT Earnings History — EPS Actual vs. Analyst Estimates
Track Kalbe Farma Tbk PT's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 31, 2026 | 19.68 | 20.14 | -2.28% |
| Apr 30, 2026 | 22.74 | 21.58 | +5.38% |
| Mar 30, 2026 | 22.72 | 18.55 | +22.48% |
| Oct 27, 2025 | 14.44 | 14.81 | -2.50% |
| Jul 31, 2025 | 19.78 | 19.24 | +2.81% |
| Apr 28, 2025 | 23.57 | 22.61 | +4.25% |
| Dec 31, 2024 | 18.82 | 16.62 | +13.24% |
| Oct 30, 2024 | 12.41 | 17.26 | -28.10% |